T. Rowe Price Associates »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 2.6M 1.81

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1

Franklin Resources
Tenor Capital Management
D. E. Shaw & Co
Piper Jaffray & Co.
FMR
Lord, Abbett & Co
Invesco
T. Rowe Price Associates
Bnp Paribas Investment Partners
SSI Investment Management
Agf Management
Rock Springs Capital Management
Citigroup
Barclays
Putnam Investments

View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1